Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rangering i aksjer #31190
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Aksjekurs
$0.03808538
Markedsverdi
$14.04M
Endring (1 dag)
-3.57%
Endring (1 år)
6.63%
Land
AU
Handel BCAL Diagnostics Limited (BDX)

Kategori

Historikk for aksjesplitt for BCAL Diagnostics Limited (BDX)
Aksjen BCAL Diagnostics Limited (symbol: BDX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én BDX-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 BDX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US